Director/PDMR Shareholding

RNS Number : 5904W
Surgical Innovations Group PLC
15 November 2017
 

Surgical Innovations Group plc

(the "Company")

 

Director/PDMR Shareholding

 

The Company was notified on 14 November 2017 that Adam Power, Group Development Director, had made the following purchases of ordinary shares of 1 penny each in the Company ("Shares") for his family.

 

Date

No. of Shares

Price




27 September 2017

27,612

3.6p

10 November 2017

29,690

3.348p

 

Following the purchases, the beneficial holding of Adam Power is 31,307,302 Shares, representing approximately 4.0% of the issued share capital of the Company.

 

The information below, set out in accordance with the requirements of the EU Market Abuse

Regulation, provides further detail on shares acquired.

 

For further information please contact:

 

Surgical Innovations Group plc

www.sigroupplc.com

Nigel Rogers, Executive Chairman

Tel: 0113 230 7597

Melanie Ross, COO & CFO

 

 

 

WH Ireland Limited (NOMAD & Broker)

Tel: 0113 394 6600

Tim Feather

Alex Bond

 

 

 

Walbrook PR  (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

                                                        Mob: 07584 391 303

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Power

2

Reason for the notification

a)

Position/status

Group Development Director, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

 

GB0004016704

b)

Nature of the transactions

Purchases of Ordinary Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

3.6p

27,612

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

27,612

£994

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Power

2

Reason for the notification

a)

Position/status

Group Development Director, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

 

GB0004016704

b)

Nature of the transactions

Purchases of Ordinary Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

3.348p

29,690

 

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

29,690

£994

e)

Date of the transaction

10 November 2017

f)

Place of the transaction

London Stock Exchange, AIM

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBBBDBXSBBGRU
UK 100